Characterization of the Oxazinomycin Biosynthetic Pathway Revealing the Key Role of a Nonheme Iron-Dependent Mono-oxygenase

Daan Ren,Yu-Hsuan Lee,Shao-An Wang,Hung-wen Liu
DOI: https://doi.org/10.1021/jacs.2c04080
IF: 15
2022-06-10
Journal of the American Chemical Society
Abstract:Oxazinomycin is a <i>C</i>-nucleoside natural product with antibacterial and antitumor activities. In addition to the characteristic <i>C</i>-glycosidic linkage shared with other <i>C</i>-nucleosides, oxazinomycin also features a structurally unusual 1,3-oxazine moiety, the biosynthesis of which had previously been unknown. Herein, complete in vitro reconstitution of the oxazinomycin biosynthetic pathway is described. Construction of the <i>C</i>-glycosidic bond between ribose 5-phosphate and an oxygen-labile pyridine heterocycle is catalyzed by the <i>C</i>-glycosidase OzmB and involves formation of an enzyme-substrate Schiff base intermediate. The DUF4243 family protein OzmD is shown to catalyze oxygen insertion and rearrangement of the pyridine <i>C</i>-nucleoside intermediate to generate the 1,3-oxazine moiety along with the elimination of cyanide. Spectroscopic analysis and mutagenesis studies indicate that OzmD is a novel nonheme iron-dependent enzyme in which the catalytic iron center is likely coordinated by four histidine residues. These results provide the first example of 1,3-oxazine biosynthesis catalyzed by an unprecedented iron-dependent mono-oxygenase.
chemistry, multidisciplinary
What problem does this paper attempt to address?